Nanotoxicity: Challenging the myth of nano-specific toxicity

Current Opinion in Biotechnology

Volumn 24, Issue 4, 2013, Pages 724-734

  Donaldson, Ken ^a,b   Poland, Craig A ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b INSTITUTE OF OCCUPATIONAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICALLY EFFECTIVE DOSE; IN COMPOSITIONS; NANOTOXICITY; SHAPE AND SIZE; TOXICOKINETICS; WIDE SPECTRUM;

DIGITAL STORAGE; HAZARDS; NANOPARTICLES; RISK ASSESSMENT;

TOXICITY;

IRON; NANOMATERIAL; NANOPARTICLE; TRANSITION ELEMENT;

BIOLOGICALLY EFFECTIVE DOSE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CONTAMINATION; HUMAN; LUNG DEPOSIT; LUNG FUNCTION; NANOTOXICITY; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SOLUBILITY; SURFACE PROPERTY; TOXICITY; TOXICOKINETICS;

HUMANS; LUNG; NANOPARTICLES; NANOTECHNOLOGY; RISK ASSESSMENT;

EID: 84880958977     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2013.05.003     Document Type: Review

References (90)

1. Hobson D.W. Commercialization of nanotechnology. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:189-202.
2. The Royal S, Royal Academy of E Nanoscience and Nanotechnologies: Opportunities and Uncertainties 2004.
3. BSI Nanotechnologies. Terminology and Definitions for Nano-objects. Nanoparticle, Nanofibre and Nanoplate 2009, British Standards Institute.
4. OECD Inhalation toxicity testing: expert meeting on potential revisions to OECD test guidelines and guidance. Series on the Safety of Manufactured Nanomaterials 2012, Organisation for Economic Co-operation and Development.
5. HSE Risk Management of Carbon Nanotubes 2009.
6. Aitken R.H., S. PetersS., Poland C.A., Hansen S.F., Holmqvist J., Ross B.L., Varet J. Specific Advice on Fulfilling Information Requirements for Nanomaterials under REACH (Rip-oN2) Final Project Report 2011, Institute of Occupational Medicine.
7. Aitken R.A., Bassan A., Friedrichs S., Hankin S.M.H., Hansen S.F., Holmqvist J., Peters S., Poland C.A., Tran C.L. Specific Advice on Exposure Assessment and Hazard/Risk Characterisation for Nanomaterials under REACH (Rip-oN3) Final Project Report 2011, Institute of Occupational Medicine.
8. Auffan M., Rose J., Bottero J.Y., Lowry G.V., Jolivet J.P., Wiesner M.R. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nanotechnol 2009, 4:634-641.
9. Fubini B., Ghiazza M., Fenoglio I. Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology 2010, 4:347-363.
10. Commission T.E. Commission recommendation of 18 October 2011 on the definition of nanomaterial 2011/696/EU). Off J Eur Union 2011.
11. Norppa H., Catalan J., Falck G., Hannukainen K., Siivola K., Savolainen K. Nano-specific genotoxic effects. J Biomed Nanotechnol 2011, 7:19.
12. Donaldson K., Schinwald A., Murphy F., Cho W.S., Duffin R., Tran L., Poland C. The biologically effective dose in inhalation nanotoxicology. Acc Chem Res 2012.
13. Povey A. Molecular assessment of exposure, effect, and effect modification. Epidemiology of Work Related Diseases 2008, 463-484. BMJ Publishing Group.
14. Pratt P.C., Kilburn K.K. Extent of pulmonary pigmentation as an indicator of particulate environmental air pollution. Inhaled Particles III: Proceedings 1971, 661-670. Gresham Books. W.H. Walton (Ed.).
15. Ruckley V.A., Fernie J.M., Chapman J.S., Collings P., Davis J.M., Douglas A.N., Lamb D., Seaton A. Comparison of radiographic appearances with associated pathology and lung dust content in a group of coalworkers. Br J Ind Med 1984, 41:459-467.
16. Donaldson K., Tran C.L., Borm P. The toxicology of inhaled particles: summing up an emerging conceptual framework. Particle Toxicology 2006, 413-424. Taylor & Francis. K. Donaldson, P. Borm (Eds.).
17. Morrow P.E. Dust overloading of the lungs: update and appraisal. Toxicol Appl Pharmacol 1992, 113:1-12.
18. Oberdorster G., Ferin J., Morrow P.E. Volumetric loading of alveolar macrophages (AM): a possible basis for diminished AM-mediated particle clearance. Exp Lung Res 1992, 18:87-104.
19. Oberdorster G., Ferin J., Lehnert B.E. Correlation between particle-size, in-vivo particle persistence, and lung injury. Environ Health Perspect 1994, 102.
20. Tran C.L., Buchanan D., Cullen R.T., Searl A., Jones A.D., Donaldson K. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal Toxicol 2000, 12:1113-1126.
21. Driscoll K.E. Role of inflammation in the development of rat lung tumors in response to chronic particle exposure. Inhal Toxicol 1996, 8 Suppl:139-153.
22. Duffin R., Tran L., Brown D., Stone V., Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 2007, 19:849-856.
23. Veronesi B., de Haar C., Lee L., Oortgiesen M. The surface charge of visible particulate matter predicts biological activation in human bronchial epithelial cells. Toxicol Appl Pharmacol 2002, 178:144-154.
24. Light W.G., Wei E.T. Surface charge and asbestos toxicity. Nature 1977, 265:537-539.
25. Light W.G., Wei E.T. Surface charge and hemolytic activity of asbestos. Environ Res 1977, 13:135-145.
26. Oortgiesen M., Veronesi B., Eichenbaum G., Kiser P.F., Simon S.A. Residual oil fly ash and charged polymers activate epithelial cells and nociceptive sensory neurons. Am J Physiol Lung Cell Mol Physiol 2000, 278:L683-L695.
27. Cho W.S., Duffin R., Thielbeer F., Bradley M., Megson I.L., Macnee W., Poland C.A., Tran C.L., Donaldson K. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal-oxide nanoparticles. Toxicol Sci 2012, 126:469-477.
28. Mura S., Hillaireau H., Nicolas J., Le Droumaguet B., Gueutin C., Zanna S., Tsapis N., Fattal E. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int J Nanomed 2011, 6:2591-2605.
29. Greish K., Thiagarajan G., Herd H., Price R., Bauer H., Hubbard D., Burckle A., Sadekar S., Yu T., Anwar A., et al. Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology 2012, 6:713-723.
30. Karlsson H.L., Gustafsson J., Cronholm P., Moller L. Size-dependent toxicity of metal oxide particles-a comparison between nano- and micrometer size. Toxicol Lett 2009, 188:112-118.
31. Aust A., Ball J., Hu A., Lighty J., Smith K., Straccia A., Veranth J., Young W. Particle Characteristics Responsible for Effects on Human Lung Epithelial Cells 2002, Research Report-Health Effects Institute.
32. Donaldson K., Brown D.M., Mitchell C., Dineva M., Beswick P.H., Gilmour P., MacNee W. Free radical activity of PM10: iron-mediated generation of hydroxyl radicals. Environ Health Perspect 1997, 105:1285-1289.
33. Gilmour P.S., Brown D.M., Lindsay T.G., Beswick P.H., MacNee W., Donaldson K. Adverse health effects of PM10 particles: involvement of iron in generation of hydroxyl radical. Occup Environ Med 1996, 53:817-822.
34. Kagan V.E., Tyurina Y.Y., Tyurin V.A., Konduru N.V., Potapovich A.I., Osipov A.N., Kisin E.R., Schwegler-Berry D., Mercer R., Castranova V., et al. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. Toxicol Lett 2006, 165:88-100.
35. Wilson M.R., Lightbody J.H., Donaldson K., Sales J., Stone V. Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxicol Appl Pharmacol 2002, 184:172-179.
36. Nagai H., Ishihara T., Lee W.H., Ohara H., Okazaki Y., Okawa K., Toyokuni S. Asbestos surface provides a niche for oxidative modification. Cancer Sci 2011, 102:2118-2125.
37. Gazzano E., Turci F., Foresti E., Putzu M.G., Aldieri E., Silvagno F., Lesci I.G., Tomatis M., Riganti C., Romano C., et al. Iron-loaded synthetic chrysotile: a new model solid for studying the role of iron in asbestos toxicity. Chem Res Toxicol 2007, 20:380-387.
38. McNeilly J.D., Jimenez L.A., Clay M.F., MacNee W., Howe A., Heal M.R., Beverland I.J., Donaldson K. Soluble transition metals in welding fumes cause inflammation via activation of NF-kappaB and AP-1. Toxicol Lett 2005, 158:152-157.
39. McNeilly J.D., Heal M.R., Beverland I.J., Howe A., Gibson M.D., Hibbs L.R., MacNee W., Donaldson K. Soluble transition metals cause the pro-inflammatory effects of welding fumes in vitro. Toxicol Appl Pharmacol 2004, 196:95-107.
40. 3+]. Arch Biochem Biophys 1992, 298:646-650.
41. Kamp D.W., Graceffa P., Pryor W.A., Weitzman S.A. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 1992, 12:293-315. (Review).
42. Sanchez V.C., Pietruska J.R., Miselis N.R., Hurt R.H., Kane A.B. Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos?. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:511-529.
43. Fahmy B., Cormier S.A. Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells. Toxicol In Vitro 2009, 23:1365-1371.
44. Turci F., Tomatis M., Lesci I.G., Roveri N., Fubini B. The iron-related molecular toxicity mechanism of synthetic asbestos nanofibres: a model study for high-aspect-ratio nanoparticles. Chemistry 2011, 17:350-358.
45. Liu X., Guo L., Morris D., Kane A.B., Hurt R.H. Targeted removal of bioavailable metal as a detoxification strategy for carbon nanotubes. Carbon 2008, 46:489-500.
46. Pumera M., Miyahara Y. What amount of metallic impurities in carbon nanotubes is small enough not to dominate their redox properties?. Nanoscale 2009, 1:260-265.
47. Ambrosi A., Pumera M. Redox-active nickel in carbon nanotubes and its direct determination. Chemistry 2012, 18:3338-3344.
48. Giovanni M., Ambrosi A., Pumera M. Direct determination of bioavailable molybdenum in carbon nanotubes. Chemistry 2011, 17:1806-1810.
49. Thompson D.F., Fowler H.W., Fowler F.G. The concise Oxford dictionary of current English 1995, Clarendon Press.
50. BSI EN 481: Workplace Atmospheres. Size Fraction Definitions for Measurement of Airborne Particles 1993.
51. Human respiratory tract model for radiological protection: a report of a task group of the International Commission on Radiological Protection; adopted in September 1993 1994, Pergamon.
52. Barbieri P.G., Mirabelli D., Somigliana A., Cavone D., Merler E. Asbestos fibre burden in the lungs of patients with mesothelioma who lived near asbestos-cement factories. Ann Occup Hyg 2012, 56:660-670.
53. Dodson R.F., Williams M.G., Corn C.J., Brollo A., Bianchi C. Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am Rev Respir Dis 1990, 142:843-847.
54. Dufresne A., Harrigan M., Masse S., Begin R. Fibers in lung tissues of mesothelioma cases among miners and millers of the township of Asbestos, Quebec. Am J Ind Med 1995, 27:581-592.
55. Hesterberg T.W., Axten C., McConnell E.E., Hart G.A., Miiller W., Chevalier J., Everitt J., Thevenaz P., Oberdorster G. Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the syrian golden hamster. Part I. Results of a subchronic study and dose selection for a chronic study. Inhal Toxicol 1999, 11:747-784.
56. Sturm R., Hofmann W. A theoretical approach to the deposition and clearance of fibers with variable size in the human respiratory tract. J Hazard Mater 2009, 170:210-218.
57. WHO Determination of Airborne Fibre Number Concentrations. A Recommended Method, by Phase-contrast Optical Microscopy Membrane Filter Method 1997.
58. Jones A.D. Respiable industrial fibres: deposition, clearance and dissolution in animal models. Ann Occup Hyg 1993, 37:211-226.
59. Donaldson K., Murphy F., Duffin R., Poland C. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010, 7:5.
60. Kuschner M., Wright G. The Effects of Intratracheal Instillation of Glass Fiber of Varying Sizes in Guinea Pigs 1976, 151-169.
61. Archer V.E. Carcinogenicity of fibers and films: a theory. Med Hypotheses 1979, 5:1257-1262.
62. Poland C.A., Duffin R., Kinloch I., Maynard A., Wallace W.A., Seaton A., Stone V., Brown S., Macnee W., Donaldson K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008, 3:423-428.
63. Murphy F.A., Poland C.A., Duffin R., Al-Jamal K.T., Ali-Boucetta H., Nunes A., Byrne F., Prina-Mello A., Volkov Y., Li S., et al. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol 2011, 178:2587-2600.
64. Poland C.A., Byrne F., Cho W.S., Prina-Mello A., Murphy F.A., Davies G.L., Coey J.M., Gounko Y., Duffin R., Volkov Y., et al. Length-dependent pathogenic effects of nickel nanowires in the lungs and the peritoneal cavity. Nanotoxicology 2012, 6:899-911.
65. Hamilton R.F., Wu N., Porter D., Buford M., Wolfarth M., Holian A. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part Fibre Toxicol 2009, 6:35.
66. Stanton M.F., Layard M., Tegeris A., Miller E., May M., Morgan E., Smith A. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst 1981, 67:965-975.
67. Schinwald A., Murphy F.A., Prina-Mello A., Poland C.A., Byrne F., Movia D., Glass J.R., Dickerson J.C., Schultz D.A., Jeffree C.E., et al. The threshold length for fiber-induced acute pleural inflammation: shedding light on the early events in asbestos-induced mesothelioma. Toxicol Sci 2012, 128:461-470.
68. Tsilibary E.C., Wissig S.L. Absorption from the peritoneal cavity: SEM study of the mesothelium covering the peritoneal surface of the muscular portion of the diaphragm. Am J Anat 1977, 149:127-133.
69. Schinwald A., Chernova T., Donaldson K. Use of silver nanowires to determine thresholds for fibre length-dependent pulmonary inflammation and inhibition of macrophage migration in vitro. Part Fibre Toxicol 2012, 9:47.
70. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L., Battelli L.A., Schwegler-Berry D., Castranova V., Porter D.W. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre Toxicol 2010, 7:28.
71. Sanchez V.C., Jachak A., Hurt R.H., Kane A.B. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem Res Toxicol 2012, 25:15-34.
72. Schinwald A., Murphy F.A., Jones A., MacNee W., Donaldson K. Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. ACS Nano 2012, 6:736-746.
73. Kreyling W.G., Semmler M., Erbe F., Mayer P., Takenaka S., Schulz H., Oberdorster G., Ziesenis A. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 2002, 65:1513-1530.
74. Kreyling W.G., Semmler-Behnke M., Seitz J., Scymczak W., Wenk A., Mayer P., Takenaka S., Oberdorster G. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol 2009, 21(Suppl 1):55-60.
75. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Lunts A., Kreyling W., Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002, 65:1531-1543.
76. Semmler-Behnke M., Kreyling W.G., Lipka J., Fertsch S., Wenk A., Takenaka S., Schmid G., Brandau W. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 2008, 4:2108-2111.
77. Sharma H., Bell I., Schofield J., Bird G. Primary peritoneal mesothelioma: case series and literature review. Clin Res Hepatol Gastroenterol 2011, 35:55-59.
78. Mitchev K., Dumortier P., De V.P. 'Black Spots' and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases. Am J Surg Pathol 2002, 26:1198-1206.
79. Sadauskas E., Jacobsen N.R., Danscher G., Stoltenberg M., Vogel U., Larsen A., Kreyling W., Wallin H. Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation. Chem Cent J 2009, 3:16.
80. LeFevre M.E., Green F.H., Joel D.D., Laqueur W. Frequency of black pigment in livers and spleens of coal workers: correlation with pulmonary pathology and occupational information. Hum Pathol 1982, 13:1121-1126.
81. Slavin R.E., Swedo J.L., Brandes D., Gonzalez-Vitale J.C., Osornio-Vargas A. Extrapulmonary silicosis: a clinical, morphologic, and ultrastructural study. Hum Pathol 1985, 16:393-412.
82. Eide J., Gylseth B., Skaug V. Silicotic lesions of the bone marrow: histopathology and microanalysis. Histopathology 1984, 8:693-703.
83. Miranda R.N., McMillan P.N., Pricolo V.E., Finkelstein S.D. Peritoneal silicosis. Arch Pathol Lab Med 1996, 120:300-302.
84. NIOSH Current Intelligence Bulletin 63: Occupational Exposure to Titanium Dioxide 2011, National Institute for Occupational Safety and Health.
85. Krug H.F., Wick P. Nanotoxicology: an interdisciplinary challenge. Angew Chem Int Ed Engl 2011, 50:1260-1278.
86. Clift M.J., Gehr P., Rothen-Rutishauser B. Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative. Arch Toxicol 2011, 85:723-731.
87. Oberdorster G. Lung particle overload - implications for occupational exposures to particles. Regulat Toxicol Pharmacol 1995, 21:123-135.
88. Donaldson K., Duffin R., Langrish J.P., Miller M.R., Mills N.L., Poland C.A., Raftis J., Shah A., Shaw C.A., Newby D.E. Nanoparticles and the cardiovascular system: a critical review. Nanomedicine (Lond) 2013, 8:403-423.
89. Burello E., Worth A.P. A theoretical framework for predicting the oxidative stress potential of oxide nanoparticles. Nanotoxicology 2010, 1-8.
90. Zhang H., Ji Z., Xia T., Meng H., Low-Kam C., Liu R., Pokhrel S., Lin S., Wang X., Liao Y.P., et al. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano 2012, 6:4349-4368.